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A large body of evidence exists demonstrating that the recognition of viral antigens 
by cytotoxic thymus (T) -derived lymphocytes (CTL) 1 is virus specific and restricted 
by gene products encoded in the major histocompatibility complex (1). In the mouse, 
these restricting genes have been mapped to the H-2K and H-2D regions (1). Indeed, 
a single mutation in one of these loci can result in failure of antiviral CTL to recognize 
virus-infected  cells  (2).  Recent  biochemical  studies  have  demonstrated  that  the 
serologically detected  H-2  antigens are  the H-2K and  H-2D  region-encoded gene 
products that serve as restriction antigens for H-2-restricted recognition (3-5). 
Viral specificity is a consequence of the insertion of specific viral proteins into the 
surface  membrane;  once  integrated  into  the  plasma  membrane  they presumably 
interact with H-2 antigens, creating immunogenic complexes that are recognized by 
antiviral  effector cells.  Two  mechanisms  that  allow  membrane  insertion  of viral 
proteins have been  identified:  (a)  fusion of the viral envelope with the target cell 
membrane  (6),  and/or  (b)  insertion  from  the  cytoplasmic side  after  viral  protein 
synthesis (7, 8). In addition, studies with liposomes (9)  and reconstituted membrane 
vesicles (8, 10, 11) have demonstrated that viral and H-2 antigens must be integrated 
into the same lipid bilayer to trigger antiviral CTL. 
Once viral proteins have been inserted into the plasma membrane, it is not clear 
whether they remain independent of H-2 antigens or form transient, intermolecular 
associations. Co-capping studies have suggested a  fairly stable association (reviewed 
in 12). In some studies, cell surface associations appear to be biologically important. 
For example,  Friend virus effector cells recognize this virus in  the context of only 
those  H-2  antigens  that  are  selectively associated  into  the  mature  particle  (13). 
Antibodies to H-2K  b but not H-2D  b co-cap vesicular stomatitis virus (VSV) antigens; 
recognition by anti-VSV CTL is restricted solely to the K-end in this haplotype (14). 
It should be noted, however, that these associations are induced and in many of these 
studies their significance has not been accurately assessed (12). 
Recent studies have demonstrated that the H-2D region is more complicated than 
initially proposed.  Immunochemical and  serological  techniques  have  identified at 
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least  four H-2D-encoded gene products:  D,  L,  M,  and  R  (15-18).  In  view of this 
complexity, it  is  important  to  first  identify which  antigens  function  as  restriction 
molecules before evaluating the biological significance of viral/H-2 antigen membrane 
associations.  For this  reason,  we  have performed experiments designed  to  identify 
which H-2 molecules function as restriction antigens for anti-VSV CTL. The results 
of our studies are the subject of this report. 
Materials and Methods 
Mice.  Mice  were  obtained  from  our  animal  colony  at  the  University  of Texas  Health 
Science Center. The H-2 haplotype of the strains used are listed in Table I. 
Virus.  VSV of the Indiana serotype (VSV IND) was prepared by passage of the virus stock 
in the rat cell line R(B77). The source and culture conditions of R(B77)  have been previously 
described (19).  VSV was titered by a  plaque assay using R(B77)  monolayers (19). 
Cells.  P815 tumor cells (a DBA/2 mastocytoma)  were maintained by biweekly passage in 
vitro  in  RPMI  1640  medium  supplemented  with  10%  fetal  calf  serum  and  antibiotics. 
Alloreactive cytotoxic cells were induced following previously published procedures (20).  Spleen 
cells obtained from mice immunized  1-2 mo previously with  10  s plaque-forming units  (PFU) 
of VSV were restimulated  in vitro with VSV-infected stimulator cells to generate secondary 
anti-VSV CTL. The procedure has been described in detail elsewhere (8). Secondary anti-VSV 
CTL were used in all experiments described in the report. 
Assay for CTL Activity.  CTL activity was measured using a standard chromium release assay 
(20).  Concanavalin A (Con A) -stimulated lymphoblast targets were radiolabeled with 51Cr and 
left uninfected or infected with VSV as previously described (8). Various numbers of normal or 
immune lymphocytes were added to a constant number (104) of target cells in microtiter plates. 
After 4 h of incubation at 37°C, the cells were pelleted by centrifugation and the supernatant 
measured for radioactivity. Cold target competition analysis was performed following previously 
published  procedures  (21)  using a  constant  number  of effector cells (usually  106) and  target 
cells (104 ) and various numbers of inhibitor cells. 
When  various antisera  or hybridoma  products  were tested  for their ability to inhibit  CTL 
activity, labeled targets were incubated with the indicated quantities of antibodies for 45 rain 
at 4°C. The effector cells were then added, and the mixtures were incubated and processed as 
described for the CTL assay. 
TABLE  I 
H-2 Genotypes of Strains Used 
Strain 
H-2 gene 
K  D  L  M*  R* 
BALB/c, B10.D2, DBA/2  d  d  d:~  d:l:  d:l: 
n-2  ~"1  d  d§  d§  --II  d 
H-2  d~  d  d  --  d  -- 
B 10.D2(RI03)  d  b  .¶ 
B10.D2(R107)  b  d  d**  d  d 
B 10.A(5R)  b  d  d  d  d 
B10.BR  k  k 
* M and R  molecules  are assumed  to be controlled by genes separate from 
H-2D or -L. However, these molecules could be precursors  or modifications 
of H-2D or H-2L (17). 
:~Alleles  of H-2  genes.  Data  from  refs.  17,  18  and  T.  Hansen,  personal 
communication. BI0.D2 and DBA/2 are assumed  to express H-2M  d. 
§ Altered by mutation. 
[] Alloantigen not detected. 
¶ Not typed. 
** Typed by derivation; H-2M alloantigen is assumed. 780  H-2L-RESTRICTED  ANTIVIRAL CYTOTOXIC  T  LYMPHOCYTES 
Antisera and Monoclonal Antibodies.  Mice were given multiple injections of 3 ×  10  v spleen cells 
approximately every 2 wk. Blood samples were obtained from the retro-orbital sinus and tested 
for cytotoxic activity. Only sera that  contained  high  cytotoxic titers  (>1/2,000)  and could 
specifically  immunopreeipitate H-2 antigens from cell-free lysates were used in these studies. 
Hybridomas specific for various H-2 antigens were kindly provided by Dr. Ted Hansen (Merck 
Institute for Therapeutic Research).  The preparation and characterization of these  reagents 
has been previously described  (22). Two monoclonal antibodies have anti-H-2.65 specificity 
(an H-2L  a determinant); 23-10-1 is an IgM antibody and 30-5-7 is an IgG2a antibody. A third 
monoclonal antibody, 34-2-12, has anti-H-2.4 specificity  (this antibody reacts with H-2D  a but 
not H-2L  d or H2Rd;  K. Ozato, S. Epstein, J. A. Bluestone,  S. O. Sharrow, T. Hanson, and D. 
H. Sachs, manuscript in preparation) and is an IgG2a antibody. Antisera and monoclones are 
listed in Table II. 
Results 
Failure  of Anti-VSV  CTL  to  Recognize  VSV  in  the  Context of H-2Kd-encoded  Gene 
Products.  To determine ifVSV is recognized in the context of H-2K  d- and/or H-2D  d- 
encoded gene products, BALB/c anti-VSV effector cells were tested against a  panel 
of VSV-infected target cells. The results, presented in Fig.  1, demonstrate that these 
effector cells are H-2 restricted  and  virus specific, as uninfected  or Sendai-infected 
B10.D2 (K a D d) targets are not lysed (panels A and B), whereas B10.D2-VSV targets 
are killed (panel C). The fact that maximum isotope release from B 10.D2-VSV target 
cells (panel C) is only 55% of the total suggests that only a  portion of VSV-infected 
Con A lymphoblasts are susceptible to lysis. 
In some but not all experiments, weak lysis also occurred against both uninfected 
and VSV-infected C57BL/6 (H-KbD~  targets as well as several other H-2-unrelated 
target  cells  (data  not  shown).  This  result  may reflect  the  presence of crossreactive 
CTL clones; or alternatively, the generation of anti-H-2 CTL during in vitro culture. 
Whatever the mechanism, it is clear that direct measurement ofcytotoxicity is not the 
best  approach  to  determine  the  restriction  loci  for VSV  recognition.  Therefore,  to 
more accurately assess whether  H-2K  d- or H-2Dd-encoded  molecules associate with 
VSV to create target antigens for anti-VSV CTL, we performed cold target compe- 
tition experiments using BALB/c (K a D a) anti-VSV CTL and B10.D2-VSV  (H-2 a) 
targets.  These  studies  demonstrated  that  only  B10.D2  (K a  D a)  and  B10.A(5R) 
(K  b  Da)-infected  inhibitors  blocked  the  lysis  of  B10.D2-VSV  targets  (Fig.  2); 
B 10.D2(R 103)(K a D b) (R 103) -VSV inhibitors did not block the cytotoxic activity of 
BALB/c anti-VSV  CTL.  Although  the  inhibitory  activity of B10.A(5R)-VSV  cells 
seen  in  this  experiment  was  less  than  that  of B10.D2-infected  cells,  this  was  not 
TAaLE II 
Serological Reagents 
Anti-H-2  d  Refer- 
Antiserum or monoclone  Donor/recipient  specificity  ence 
B10.BR anti-B 10.D2  B 10.D2/B10.BR  H-2  d 
R 103 anti-B 10.D2  B 10.D2/R 103  H-2D-end 
23-10-1  BALB/c/H-2  din2  H-2L  a (2.65)  22 
30-5-7  BALB/c/H-2  din2  H-2L  d (2.65)  22 
34-2-12  (BD)F~/C3H  H-2D  d (2.4) 
The reactivity of the two antisera represents potential specificities.  The monoclonal 
reagents are specific  for the H-2a-encoded antigens indicated. Monoclone 34-2-12 does 
not react with H-2L  d or -R  d (T.  Hansen, personal communication). 7m 
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FIo.  1.  Viral specificity and H-2 restriction of anti-VSV CTL. BALB/c mice primed in vivo with 
VSV were cultured either alone  (©)  or  with  VSV-infected,  syngeneic stimulator  (0)  cells  as 
previously described (8). Anti-VSV cytotoxic activity was then tested against the indicated panel of 
target cells in the 5aCr release assay. 
observed  in  a  repeat  experiment.  The  data  from  this  experiment,  however,  may 
indicate that the presence of H-2K  b, an antigen that restricts in the H-2 b haplotype, 
affects antigen presentation by the D-end of H-2  d. 
The data above suggest that BALB/c  anti-VSV killer cells are restricted solely by ii ° 
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FIG.  2.  Failure of H-2 K a region-compatible inhibitors to block the cytotoxic activity of BALB/c 
anti-VSV CTL.  The competition assay was performed using various  numbers of inhibitor cells 
together with a constant number of effector cells (106) and radiolabeled B 10.D2-VSV targets (104). 
The percent release in the absence of inhibitors was 55%, whereas 20% of the isotope was released 
when target cells were incubated with primed cells that were not reincubated with VSV in vitro 
(control release). Percent inhibition =  1-([percent specific release in presence ofinhibitorsl/[percent 
specific release in absence of inhlbitors]) X  100. BI0.D2  (O);  BI0.D2-VSV  (0);  B10.A(5R)-VSV 
(*); R103-VSV (+); B10.D2-Sendai (X). 
TABLE  III 
Failure of H-2 d''t and H-2 a'~ Mice to Mount a Secondary 
Anti- VS V CTL Response * 
Strain 
E/T ratio 
100  50  10 
B10.D2  505  36  14 
BALB/c  54  46  19 
H-2  am1  10  8  3 
H-2  am2  7  7  2 
* Mice were primed in vivo with l0  s PFU of VSV. Approximately 6 wk later, 
the animals were killed and their spleen cells restimulated in  vitro for 5 d 
with VSV-infected syngeneic cells. 
:~ Percent  specific release  from  VSV-infected P815  targets.  Percent  specific 
release  =  percent  release  in  restimulated  cultures  -  percent  release  in 
unstimulated cultures. 
products  encoded  in  the  H-2D  region  of the  H-2 d  haplotype.  Further  observations 
support  this view:  (a)  B10.A(5R)  (K b D d)  mice  mount  a  strong  secondary  anti-VSV 
CTL  response  when  tested  against  P815-VSV  (K a  D a)  targets,  whereas  R103 
(K d D b)  mice  are nonresponders  (unpublished  data);  and  (b)  H-2 din1  (K a D am~) and 
H-2  dmz  (K a D am2)  mice  do  not  mount  a  secondary  anti-VSV  CTL  response  (Table RICHARD  CIAVARRA  AND  JAMES  FORMAN  783 
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F[o.  3.  Evidence that BALB/c VSV CTL are restricted to the H-2 D  region but not the H-2D d 
locus.  The protocol was the same as that described in the legend for Fig. 2. The competition assay 
was performed using both P815-VSV  (top panel) and BALB-VSV (bottom panel)  targets. In the 
absence of inhibitor cells, 68% and 56% of the isotope was released from P815-VSV and BALB/c- 
VSV targets,  respectively.  Spontaneous release was  10%  for the  P815-VSV  targets  and  35%  for 
BALB/c-VSV  targets. The E/T ratios were 25  and  100:1,  respectively. The inhibitor cells  were 
BALB/c (O); BALB/c-VSV (*); H-2'~LVSV (O);  and H-2a~-VSV (X). 
III). These latter H-2 mutant mouse strains have alterations in H-2D region molecules 
but possess a normal H-2K  d antigen (23, 24). 
Evidence  that  BALB/c  Anti-VSV  Cytotoxic  Cells  Are  Not  Restricted  by  the  H-2D d 
Molecule.  The previous data suggest that in the H-2 a haplotype, VSV is recognized 
in  the context of H-2D d and not H-2K d. This hypothesis was tested by cold target 
competition experiments using the H-2 mutant mouse strains H-2  am1 and H-2  am~. The 
H-2  am1 strain has altered H-2D and H2-L molecules and lacks H-2M  (18), whereas 
the H-2  't~ strain possesses a  normal H-2D molecule but does not express H-2L and 
H-2R  (17).  The results  presented  in  Fig.  3  demonstrate  that  unlike  BALB/c  VSV 
inhibitors, H-2  am1 and H-2  a~ VSV-infected competitor cells do not block the lysis of 784  H-2L-RESTRICTED  ANTIVIRAL CYTOTOXIC  T  LYMPHOCYTES 
P815-VSV or BALB/c-VSV target ceils in the presence of BALB/c anti-VSV killer 
cells. Because H-2  ~  mice possess a  wild-type H-2D  d molecule, these data indicate 
that VSV recognition is not restricted by H-2D a. The fact that H-2  a'~a expresses H- 
2M  a suggests that this molecule is also not involved in VSV recognition, although it 
cannot be ruled out that H-2M was affected by mutation. H-2  am1 expresses a mutant 
form  of H-2D  and  H-2L,  expresses  H-2R  (T.  Hansen,  personal  communication), 
although it is not known whether this molecule has undergone mutation, and lacks 
H-2M. Taken together, these data demonstrate that H-2D a is not the H-2D  region- 
restricting locus and suggests that H-2L a may serve in this function. 
Recognition  of VSV  is  Restricted by  the H-2L a  Molecule.  Because  the  previous data 
suggest that H-2L  d rather than H-2D  d is involved in associative recognition of VSV 
(see  Fig.  3),  we  directly evaluated the  role of H-2L  d as  a  restricting antigen. Two 
possibilities can be envisioned: either the H-2L molecule influences the orientation or 
conformation of H-2D, which facilitates an immunogenic interaction with VSV, or 
the anti-VSV T  cell receptor  is restricted by H-2L.  To discriminate between these 
possibilities, anti-H-2 sera and monoclonal anti-H-2 antibodies were tested for their 
ability to block the cytotoxic activity of anti-VSV CTL in the CTL assay. 
Antisera  prepared  against  the  whole  H-2  d  complex  (B10.BR  anti-B10.D2)  or 
antigens encoded by the D-end of H-2 a  (R103 anti-B10.D2) blocked anti-VSV CTL 
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Fxc. 4.  Inhibition of anti-VSV CTL activity with antibodies specific for the  H-2L  d molecule. 
P815-VSV targets were incubated with antisera or monoclones  before the addition of BALB/c anti- 
VSV effector cells (see Material and Methods). Percent inhibition was calculated as follows: 1- 
([percent specific release in presence of antiserum]/[percent specific release in presence of normal 
mouse serum]) ×  100, where percent specific released equals percent isotope release in stimulated 
cultures (either in the presence of immune or normal mouse serum) minus percent isotope release in 
unstimulated cultures. In this experiment, spontaneous release was 7%, whereas 27% of the isotope 
was released in the presence of normal mouse serum. E/T ratio was  100:1. The antisera and 
monoclones were: B10.BR anti-B10.D2, anti-H-2  d (O); R103 anti-B10.D2, anti-H-2Dd-region (C)); 
23-10-1, anti-H-2L  d (*); 30-5-7, anti-H-2L  a (×); 34-2-12, anti-H-2D  d (+). gW 
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FIG. 5.  Specificity  of monoclonal antibodies for H-2D  a and H-2L  d molecules.  Anti-H-2  a killer cells 
against H-2D  d or H-2Ka-end-encoded  gene products were generated in vitro and mixed with labeled 
P815 target cells that had been previously incubated with the indicated antibodies. The following 
antibodies or sera were tested: R103 anti-B10.D2 (©); B10.BR anti-B10.D2 (0);  23-10-1 (anti- 
H-2.65) (*); 30-5-7 (anti-H-2.65) (+); 34-2-12 (anti-H-2.4) (×). E/T ratio was 100:1. The net release 
in the presence of 0.05 ml normal mouse serum for the various E/T combinations used were as 
follows: (A) R103 anti-BALB/c (anti-H-2Da-end),  28%; (B) R107 anti-BALB/c (anti-H-2Kd-end), 
45%; (C) H-2  ~  anti-BALB/c (anti-H-2La,-Ra?), 12%; (D) R103 anti-H-2  a~ (anti-H-2D  a, -Ma?), 
19%. The percent inhibition was calculated as described in the legend to Fig. 4. 
activity in a  dose-dependent fashion (Fig. 4). The ability of the B10.D2(R103)  anti- 
B10.D2  (anti-D region) serum to block anti-VSV activity against P815-VSV targets 
is consistent with the view that VSV is not H-2K-end restricted. That this inhibition 
was due to antibody binding to the H-2L molecule and not to H-2D can be seen by 
the ability of hybridomas specific for H-2L  a  (H-2.65)  to block CTL activity. This is 
particularly true for the 30-5-7 (IgG2a)  monoclone, which was very inhibitory even at 
low  concentrations.  On  the  other  hand,  a  hybridoma  specific  for  H-2D  a 
(34-2-12),  but  not  other  H-2D-end-encoded molecules, had  no  inhibitory activity. 
Thus, these data clearly demonstrate that in the H-2 a  haplotype, VSV is restricted 
solely by H-2L. 
To  verify  the  specificity of these  reagents,  alloreactive  CTL  specific  for  either 
H-2K  d, -D  a, or -L  d molecules were generated and various quantities of antibody were 
then tested for their ability to block CTL activity against particular H-2 molecules. 786  Ho2L-RESTRICTED  ANTIVIRAL CYTOTOXIC  T  LYMPHOCYTES 
The data in Fig. 5 illustrate that  R103 anti-B10.D2  (anti-Dd-region) serum is D-end 
specific. For example, this serum  blocked the lytic activity of H-2D-region-specific 
alloreactive CTL (R103 anti-BALB/c) (panel A), whereas it had no effect on the lytic 
activity of B10.D2(R107)  (abbreviated  R107)  anti-BALB/c CTL  (anti-H-2K-end) 
(panel B). As a  control, we demonstrated that an antiserum  (B10.BR anti-B10.D2) 
directed against antigens from the entire anti-H-2  a haplotype blocks both anti-H-2K- 
end and anti-H-2D region CTL responses (panels A and B). A hybridoma specific for 
the H-2L  a molecule (30-5-7)  inhibited the activity of H-2  am2 anti-BALB/c CTL (anti- 
H-2L  a)  (panel C), but this antibody, as well as monoclone 23-10-1  (anti-H-2Ld), was 
not inhibitory for R103 anti-H-2  am2 effector cells (panel D). It should be noted that 
H-2  a~  anti-BALB/c  effector cells  could  potentially  display  lytic  activity  against 
H-2R,  as  H-2  ar~  animals  lack  this  molecule.  However, all  the  CTL  activity was 
blocked with the anti-H-2L  a monoclone (anti-2.65) (panel C and data from two other 
experiments [not shown] where the net isotope release at effector/target (E/T) ratio 
=  100 was 64.9 and 20.9). Therefore, these data indicate that H-2R is not recognized 
by H-2  ar~ anti-BALB/c alloreactive T  cells.  Finally, an  H-2Da-specific hybridoma 
(34-2-12)  caused no inhibition of the anti-H-2L  d CTL reaction  (panel C),  whereas 
anti-H-2D  a CTL activity was inhibited in a dose-dependent fashion (panel D). Thus, 
these antisera and hybridomas are functionally specific for individual H-2 molecules. 
In summary, because monoclones 23-10-1  and 30-5-7 are specific for H-2L  a and do 
not react against H-2R  a, and H-2  a~ mice express H-2D  a and H-2M a but their cells 
do not block CTL activity, these data indicate that H-2L, rather than H-2D, H-2M, 
or H-2R, restricts anti-VSV recognition in H-2 a mice. 
Discussion 
Anti-viral CTL are thought to play an important role in preventing the spread of 
virus infection. This is presumably achieved by the destruction of virus-infected cells 
by CTL during the eclipse period, a period before the assembly of mature infectious 
virus  particles.  This  implies  that  viral  antigens  appear  on  the  plasma  membrane 
before the release of virus progeny, a view which is substantiated by kinetic studies in 
many systems (7,  1:2). With all viruses tested to date, H-2K- or H-2D-region compat- 
ibility between effector and target cells is required for recognition of viral antigens by 
anti-viral CTL (1). 
We have demonstrated that BALB/c (H-2  a) anti-VSV CTL are similarly restricted 
by  these  same  loci;  in  this  study,  compatibility  at  H-2L  a  was  required,  whereas 
H-2Ka-restricted recognition could not be demonstrated. In addition, H-2Da-restricted 
recognition could not  be detected by cold target  competition analysis or blocking 
studies  with  an  anti-H-2Dd-specific  hybridoma.  However,  VSV  recognition  was 
completely inhibited by two H-2L  a specific monoclones. Although two other H-2D- 
region-encoded gene products, designated H-2M and -R, have been recently identified 
in the H-2  a haplotype (17,  18), these molecules do not serve as restricting loci for VSV 
recognition in this mouse strain. Thus, VSV-infected cells obtained from H-2  am1 mice 
that express H-2M but not H-2L (18) do not block the lysis of BALB/c-VSV targets 
by BALB/c effector cells in a  cytotoxic assay.  Further, the 30-5-7 monoclone (anti- 
H-2.65,  anti-H-2L  a)  does  not  react  with  the  H-2R  molecule  (17),  but  completely 
inhibits recognition of VSV-cells by BALB/c CTL. Therefore, in H-2 a mice, VSV is 
recognized exclusively in the context of H-2L  a. RICHARD CIAVARRA AND JAMES  FORMAN  787 
The  failure to  detect  H-2K and  D  locus-restricted  recognition  of this  virus  may 
indicate that VSV-G protein, the envelope glyeoprotein recognized by killer cells (25), 
may not associate in an antigenic  fashion with H-2K  d and H-2D  a molecules on the 
cell  membrane.  However,  other  explanations  are  possible  and  further  studies  are 
required to determine the basis of this unresponsiveness. 
Previous reports have indicated  that T  cells possess a  more restricted repertoire of 
responses restricted by H-2L than with H-2K or Ho2D.  For example, H-2L-restricted 
cytotoxic  responses  have not  been  detected  against  trinitrophenol  (26)  and  minor 
histocompatibility  antigens  (27).  However,  studies  by  Blanden  et  al.  (28)  have 
indicated a possible role for the H-2L molecule in T  cell recognition of viral antigens. 
These  investigators  reported  that  a  strong  H-2Da-restricted  CTL  response  against 
ectromelia virus could be elicited in BALB/c but not H-2  °m mice. Similarly, H-2  am- 
infected  macrophages  could  not  elicit  secondary,  H-2Da-restricted  anti-ectromelia 
killer  cells  from  in  vivo  primed  cells.  However,  H-2am2-infected  targets  were  as 
susceptible  to  lytic  attack  by  H-2Da-restricted  anti-ectromelia  CTL  as  BALB/c 
infected targets. These authors suggested that the H-2L  d molecule was not necessary 
for H-2Da-restricted recognition of this virus by activated cytotoxic effector cells, but 
rather that H-2L played some role, perhaps in the orientation or conformation of the 
H-2D  ° molecule, which facilitated the putative associations between H-2D  d and viral 
antigens required for triggering CTL precursors. 
Indirect evidence  for H-2La-restricted  recognition  of viral antigens  has  been  ob- 
tained  using  monoclonal  antibodies  specific for H-2Dk-encoded  determinants  (29). 
These antibodies blocked H-2Dk-restricted anti-influenza CTL activity but not anti- 
Bebaru  virus  killer  cells.  One  interpretation  of these  data  is  that  another  D-end- 
encoded  molecule,  presumably  H-2L  k,  serves as  the  restriction  antigen  for Bebaru 
virus. However, an alternative interpretation is that influenza and Bebaru virus have 
different  restriction  determinants  on  the  H-2D  k molecule.  In  the  latter  case,  these 
determinants  are  sufficiently  distant  from  the  allodeterminants  recognized  by the 
monoclonal antibodies, so that no steric hinderance by anti-Bebaru T  cells occurs. In 
support of this, Weyand et al.  (30)  have demonstrated  with  monoclonal  antibodies 
that there are different target regions on H-2 molecules. 
The  first  direct  evidence  for  the  involvement  of H-2L  gene  products  in  virus 
recognition was reported by Biddison et al. (3 I), who showed, using anti-H-2L  d- and 
H-2Dd-specific hybridomas,  that  influenza  virus  elicits  two T  cell  subsets  that  are 
restricted  by either H-2L  or H-2D.  However, because no recombinant  strains  have 
been detected that separate H-2L a from H-2D  a, it cannot be determined ifH-2L a can 
restrict  recognition  without  a  similar  activity  by H-2D  a.  For  example,  H-2L  may 
contain only one exon that can encode a  restricting region and that is duplicated  in 
the H-2D gene. On the other hand, H-2D may contain an additional  (nonduplicated) 
exon  that  can  also restrict  antigen  recognition.  This  possibility would  predict  that 
whenever H-2L restriction  is  observed for a  given antigen,  I-I-2D restriction  would 
also be found, but not vice-versa. However, the data in the present report demonstrate 
that  mouse strains with  the H-2 a haplotype use H-2L  exclusively as the restricting 
locus  for anti-VSV  CTL.  Thus,  H-2L uses a  unique  determinant  involved in H-2- 
restricted  recognition  of virus,  further substantiating  the  role of this  molecule as a 
major class I antigen. 
Finally, the fact that H-2  'a~ effector cells sensitized against BALB/c  (anti-H-2L  d, 788  H-2L-RESTRICTED  ANTIVIRAL CYTOTOXIC T  LYMPHOCYTES 
-Rd?)  were totally inhibited  from killing BALB/c target  cells  in  the presence of an 
anti-H-2L  d monoclonal antibody, indicates that H-2R does not play a functional role 
in H-2 alloreactivity mediated by CTL. 
Summary 
H-2d-encoded gene products were analyzed as restriction antigens for anti-vesicular 
stomatitis  virus  0dSV)  cytotoxic T  lymphocytes  (CTL).  Cold  target  competition 
experiments  revealed  that  VSV recognition was  H-2D  region-restricted;  H-2K-end- 
restricted recognition of VSV could not be demonstrated. That VSV is not recognized 
in the context of K-region-encoded gene products is also supported by the observation 
that H-2  ~1 and H-2  a~ mice, strains  that contain H-2K  a but have an alteration  in 
H-2L and/or H-2D/L,  are nonresponders in the CTL assay. 
Two  different  lines  of evidence  eliminated  H-2D  d,  H-2M  a,  and  H-2R  d  as  the 
restriction antigens:  (a)  H-2a~-VSV inhibitors  that express  H-2D  d and H-2M  d did 
not block the lysis of P815-VSV targets by BALB/c anti-VSV killer cells,  and  (b)  a 
hybridoma specific for H-2D  d failed to inhibit killer cell activity in this same effector/ 
target combination. However, two monoclonal antibodies specific for H-2L  a but not 
H-2R  d completely blocked anti-VSV cytotoxic acitvity. Taken together, in the H-2  a 
haplotype, anti-VSV CTL recognize VSV solely in the context of the H-2L  d molecule. 
This is the first  demonstration of the exclusive use by a  mouse strain of the H-2L 
molecule only for H-2-restricted recognition, and thus supports the notion that H-2L 
plays a major role in restricting antigen specific recognition. Finally, the fact that an 
anti-H-2L  d monoclone completely blocked  an  H-2  ~  anti-BALB/c CTL  response 
indicates that H-2R, a molecule absent in H-2  't~ but not BALB/c, does not sensitize 
H-2 alloreactive CTL. 
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